Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2015-02-28
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open Repair Versus Branched Endograft Repair for Treatment of Residual Chronic Aortic Arch Dissection During Follow-up After Open Type A Acute Ascending Aorta Replacement: Results From an International Multicenter Study.
NCT04014907
An Innovative Approach to Automated Carbon Dioxide Angiography During Endovascular Abdominal Aortic Aneurysm Repair
NCT04721951
A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection
NCT03010514
Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms
NCT03142074
Aneurysm Diameter and Surgical Outcome
NCT04422054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiac Reoperation
Patients who have previously undergone a cardiac operation with the use of BioGlue and are now undergoing a reoperation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has had BioGlue used during previous aortic surgery
* Subject is willing and able to give written informed consent for participation
Exclusion Criteria
* Subject with active infection (endocarditis)
* Subject with a history of chronic inflammatory condition which may have led to ongoing tissue damage
* Subject with a history of auto immune disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CryoLife Europa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davide Pacini, Dr
Role: PRINCIPAL_INVESTIGATOR
Cardiac Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
S.Orsola Malpighi Hospital
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIO1301.001M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.